Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies.

ABSTRACT:

Background

Heterogeneity in drug access throughout Europe may be influenced by differences in drug-assessment strategies. The EUnetHTA's assessment core model (EUnetHTA-core) and the EVIDEM's multicriteria framework are reference methodologies in this context, the latter including a wider compromise between non-contextual and contextual criteria. Compliance of 37 European Health Technology Assessment bodies (HTAb) with EUnetHTA-core has been reported, but the use of EVIDEM by this HTAb is still unknown.

Methods

To describe the uptake and use of multicriteria approaches to evaluate drug value by European HTAb using EVIDEM as reference framework, a multicriteria framework was obtained based on EVIDEM model. The criteria used for drug appraisal by HTAb was extracted from the EU

SUBMITTER: Elvira D 

PROVIDER: S-EPMC8364048 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature